Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Retroviral zinc finger inhibitors as anti-HIV agents

Oct. 18, 1996

Novel strategy for AIDS reported by UCSF researchers

Oct. 11, 1996

HIV inhibited by chemokine antagonist

Oct. 11, 1996

Ingenol derivatives as anti-HIV agents

Oct. 11, 1996

Merck & Co. cleared to market protease inhibitor in EU

Oct. 11, 1996

Anti-HIV agents from Nippon Paper

Oct. 11, 1996

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Gilead Sciences issues warning regarding Vistide

Oct. 4, 1996

Japanese patent coverage for NABI HIV immunotherapeutic

Oct. 4, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...